- Home
- DRVN vs AMLX Comparison
DRVN vs AMLX Comparison
Compare DRVN & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRVN | AMLX |
|---|---|---|
| Founded | 1972 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DRVN | AMLX |
|---|---|---|
| Price | $14.86 | $17.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | $18.33 | ★ $21.56 |
| AVG Volume (30 Days) | 1.1M | ★ 1.7M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.70 | 65.46 |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $1,862,438,000.00 | $380,786,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.53 | N/A |
| P/E Ratio | $45.85 | ★ N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $9.80 | $7.48 |
| 52 Week High | $19.74 | $19.15 |
Technical Indicators
Market Signals| Indicator | DRVN | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 62.91 | 65.22 |
| Support Level | $14.28 | $12.17 |
| Resistance Level | $15.91 | $18.88 |
| Average True Range (ATR) | 0.54 | 1.00 |
| MACD | 0.20 | 0.14 |
| Stochastic Oscillator | 77.22 | 71.76 |
Price Performance
Historical ComparisonAbout DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.